Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Author Archives: MissionIR

PCM, Inc. (PCMI) Starts Presentation at Marcum MicroCap Conference

PCM, Inc. (NASDAQ: PCMI) (formerly known as PC Mall, Inc.) is a technology solutions provider to businesses, government and educational institutions and individual consumers. The company markets its products, services and solutions through a 700+ sales force, field service teams, … Continue reading

Posted in Marcum MicroCap | Leave a comment

Pulmatrix, Inc. (PULM) Starts Presentation at Marcum MicroCap Conference

Pulmatrix NASDAQ: PULM) is a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary disease  using its clinically validated, proprietary iSPERSE technology. The company’s PUR0200 is a branded generic in clinical development for chronic obstructive pulmonary disease. … Continue reading

Posted in Marcum MicroCap | Leave a comment

BioRestorative Therapies, Inc. (BRTX) Starts Presentation at Marcum MicroCap Conference

BioRestorative Therapies (OTC: BRTX) develops therapeutic products primarily using adult stem cells. The company’s lead cell therapy candidate is formulated from autologous cultured mesenchymal stem cells for the non-surgical treatment of chronic lumbar disc disease. The treatment is intended for patients … Continue reading

Posted in Marcum MicroCap | Leave a comment

Cel-Sci Corp. (CVM) Starts Presentation at Marcum MicroCap Conference

CEL-SCI (NYSE: CVM) is primarily focused on R&D to improve the treatment of cancer and other diseases by utilizing the immune system, the body’s natural defense system. Its lead investigational therapy, Multikine, is currently being studied in a pivotal global … Continue reading

Posted in Marcum MicroCap | Leave a comment

Apivio Systems, Inc. (APVVF) Starts Presentation at Marcum Microcap Conference

Apivio Systems (OTC: APVVF) is a Canadian technology company engaged in the design, development, marketing, and sale of communications equipment and software. It has a wholly owned Korean subsidiary with a history of supplying VoIP telephone equipment and other products … Continue reading

Posted in Marcum MicroCap | Leave a comment

BIO-key International (BKYI) Starts Presentation at Marcum MicroCap Conference

BIO-key International (OTC: BKYI) provides of fingerprint biometric identification, secure mobile credentialing and user identity verification solutions to reduce risk and protect the value of their services and assets. BIO-key’s products are software based and optimized to deliver fast and … Continue reading

Posted in Marcum MicroCap | Leave a comment

BG Staffing (BGSF) Starts Presentation at Marcum MicroCap Conference

Headquartered in Plano, Texas, BG Staffing (NYSE: BGSF) is a national provider of temporary staffing services across a diverse set of industries. Through both organic growth and accretive acquisitions, the company has grown revenue to $217 million in 2015 (approximately … Continue reading

Posted in Marcum MicroCap | Leave a comment

Legacy Education Alliance, Inc. (LEAI) Starts Presentation at Marcum MicroCap Conference

Legacy Education Alliance (OTC: LEAI) offers comprehensive instruction and mentoring, primarily on the topics of real estate and financial instruments investing, through its Rich Dad Education brand. The company delivers its programs through various channels, including live courses, online trainings, … Continue reading

Posted in Marcum MicroCap | Leave a comment

Inventergy Global, Inc. (INVT) Starts Presentation at Marcum MicroCap Conference

Inventergy Global, Inc. (NASDAQ: INVT) is an intellectual property company focused on identifying, acquiring and licensing the patented technologies of market-significant technology leaders. The company leans on decades of corporate experience, market and technology expertise, and industry connections to help … Continue reading

Posted in Marcum MicroCap | Leave a comment

CorMedix, Inc. (CRMD) Starts Presentation at Marcum MicroCap Conference

CorMedix (NYSE: CRMD) is an emerging commercial-stage biopharmaceutical company that initiated a phase 3 clinical study of a novel anti-infective solution in hemodialysis patients. The company’s strategy is to seek to in-license, develop and commercialize therapeutic products for the prevention … Continue reading

Posted in Marcum MicroCap | Leave a comment